Research Foundation

AVS was applied to elementary students with ADHD and behavior disorders across two school settings. The study reported improvements in attention, impulsivity, and reading scores in the settings studied. The findings should be interpreted in light of the study design and the population examined.

Rhythmic audio-visual stimulation produced measurable electrocortical and autonomic responses — including heart rate and skin conductance changes — alongside subjective feelings of relaxation and altered arousal. The study reported electrocortical and autonomic responses to rhythmic audio-visual stimulation. The extent and significance of these responses depend on the protocol and study methods.

QEEG analysis in patients with refractory depression showed significant decreases in depression scores after four weeks of AVS at 14 Hz (beta frequency), using a crossover design with 16 participants. The mechanism — brainwave normalization visible on EEG in cortical regions associated with mood regulation — points toward AVS as a measurable neurological intervention, not just a relaxation tool.

Rhythmic visual stimulation phase-locked alpha oscillations in the visual cortex, showing that the brain actively entrains to sensory input at the same frequency. This study examined how rhythmic visual stimulation relates to alpha oscillations in the visual cortex. It provides mechanistic context for sensory entrainment, but does not establish clinical outcomes for SoundSelf.

Rhythmic visual stimuli caused local entrainment of alpha oscillations in the visual cortex and produced cyclic modulation of perceptual processing. The study reported local alpha-oscillation entrainment and changes in perceptual processing under the conditions tested.

Open-loop AVS induced delta-frequency EEG activity in older adults with chronic osteoarthritis pain and insomnia. The study reported delta-frequency EEG activity under the tested conditions. This physiological finding alone does not establish improvements in pain, sleep, or recovery.

A pilot self-care study of adults with chronic pain and insomnia found that audio-visual stimulation, used independently at home, reduced pain intensity and improved sleep. Participants reported high satisfaction and tolerability, These findings may warrant further study of AVS as a self-administered adjunct, but do not establish effectiveness across other populations or devices.

Direct EEG measurement during AVS confirmed frequency-specific changes in brainwave activity corresponding to the stimulation frequency. The study examined relationships between stimulation frequency and EEG activity. Clinical applications require evidence specific to the intervention and intended outcome.

Twenty individuals diagnosed with Major Depressive Disorder completed a 5-week intervention of music listening combined with low-frequency vibroacoustic stimulation, self-administered at home. Significant reductions in depression symptoms, anhedonia, and improvements in sleep quality and quality of life were observed, with 37% of participants meeting full clinical response criteria and approximately 62% average symptom reduction among responders. The improvements in anhedonia among responders point to vibrotactile stimulation as a potential modulator of reward-processing circuits.

Vibratory stimulation applied to the body produced significant pain alleviation — one of the earliest controlled demonstrations of what became known as vibratory analgesia. The mechanism operates at the spinal cord level, where vibration modulates nociceptive signal transmission, providing the physiological foundation for VAT's pain applications.

A mechanistic review and experimental study examining how vibration reduces pain. Findings confirmed that vibratory stimulation activates mechanoreceptors that gate pain transmission at the spinal level — These findings are relevant to proposed mechanisms of vibration-related pain modulation; they do not by themselves establish the effectiveness of a particular vibroacoustic therapy device.

In a pediatric population with juvenile arthritis, combined physical and vibroacoustic therapy produced meaningful reductions in chronic pain compared to physical therapy alone. The reported findings concern the specific intervention and population studied; further details should be reviewed in the original publication before drawing broader conclusions.

A clinical review of vibroacoustic sound therapy across patient populations found consistent improvements in pain management alongside secondary benefits including reduced anxiety, decreased muscle tension, and improved mood. The review discusses vibroacoustic sound therapy in relation to pain and other outcomes. Safety and effectiveness should be assessed against the specific protocol and patient population.

Elderly nursing home residents with depression received vibroacoustic therapy and showed measurable reductions in depressive symptoms on standardized assessment. The study reported changes in depressive symptoms among the population studied. The findings should be interpreted in context of its methods and limitations.

Low-frequency sound wave therapy in frail older adults improved functional capacity and blood circulation over the course of the intervention. The study reported changes in functional capacity and circulation following the intervention; these results should not be generalized beyond the population and protocol studied.

In individuals with Rett syndrome, combined music and vibroacoustic stimulation produced measurable neurophysiological responses including EEG changes and autonomic markers of engagement. The study reported neurophysiological responses in individuals with Rett syndrome. These findings describe responses to the tested intervention and do not establish broader clinical benefit.

Low-frequency vibratory stimulation at 40 Hz induced neurite outgrowth in mutant nerve cells (PC12m3) at approximately three times the rate produced by nerve growth factor alone — via activation of the p38 MAPK signaling pathway. This cell-based finding concerns a laboratory model and should not be interpreted as evidence of clinical effects on neurological repair or cognition.

A comprehensive review of VAT across clinical and non-clinical populations documented consistent effects on muscle tone reduction, pain relief, anxiety reduction, and relaxation. The review describes reported applications of vibroacoustic therapy across clinical and non-clinical settings; conclusions should be considered in light of the evidence available at the time.

A pilot study in a health resort environment testing a newly developed VAT device found significant improvements in relaxation, stress, and general wellbeing across participants. The pilot study examined a VAT device in a health-resort setting. Further research would be needed to establish generalizability and clinical effectiveness.

This is a secondary overview, not a peer-reviewed study or a primary research source. Use it only for background context and consult the original studies wherever possible. It should not be presented as direct evidence of SoundSelf’s effectiveness.

This is an industry-sponsored trial of a Sana Health intervention, not a study of SoundSelf. Because the trial is ongoing, results should not be inferred before findings are reported. Link to the public trial registry or sponsor’s study page so readers can verify its status and protocol.